Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?

References

• LeRoithDWernerHBeitner-JohnsonDRobertsCTJrMolecular and cellular aspects of the insulin-like growth factor I receptorEndocr Rev1995161431637540132
   PubMed Web of Science ®Google Scholar
• BraulkeTType-2 IGF receptor: a multi-ligand binding proteinHorm Metab Res19993124224610226808
   PubMed Web of Science ®Google Scholar
• RotherKIAcciliDRole of insulin receptors and IGF receptors in growth and developmentPediatr Nephrol200014755856110912518
   PubMed Web of Science ®Google Scholar
• FrascaFPandiniGScaliaPInsulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cellsMol Cell Biol1999193278328810207053
   PubMed Web of Science ®Google Scholar
• SeelyBLReichartDRTakataYYipCOlefskyJMA functional assessment of insulin/insulin-like growth factor-I hybrid receptorsEndocrinology1995136163516417895674
   PubMed Web of Science ®Google Scholar
• PandiniGFrascaFMineoRSciaccaLVigneriRBelfioreAInsulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involvedJ Biol Chem2002277396843969512138094
   PubMed Web of Science ®Google Scholar
• MyersMGJrGrammerTCWangLMInsulin receptor substrate-1 mediates phosphatidylinositol 3′-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulationJ Biol Chem199426928783287897961833
   PubMed Web of Science ®Google Scholar
• HeWCraparoAZhuYInteraction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2J Biol Chem199627111641116458662806
   PubMed Web of Science ®Google Scholar
• FantinVRSparlingJDSlotJWKellerSRLienhardGELavanBECharacterization of insulin receptor substrate 4 in human embryonic kidney 293 cellsJ Biol Chem199827310726107329553137
   PubMed Web of Science ®Google Scholar
• PelicciGLanfranconeLGrignaniFA novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transductionCell199270931041623525
   PubMed Web of Science ®Google Scholar
• GiorgettiSPelicciPGPelicciGVan ObberghenEInvolvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptorEur J Biochem19942231952028033892
   PubMedGoogle Scholar
• LamotheBBucchiniDJamiJJoshiRLInteraction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid systemFEBS Lett199537351557589433
   PubMed Web of Science ®Google Scholar
• MorrioneAValentinisBLiSOoiJYMargolisBBasergaRGrb10: A new substrate of the insulin-like growth factor I receptorCancer Res199656316531678764099
   PubMed Web of Science ®Google Scholar
• BaronVCallejaVFerrariPAlengrinFVan ObberghenEp125Fak focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-I tyrosine kinase receptorsJ Biol Chem1998273716271689507031
   PubMed Web of Science ®Google Scholar
• Arbet-EngelsCTartare-DeckertSEckhartWC-terminal Src kinase associates with ligand-stimulated insulin-like growth factor-I receptorJ Biol Chem19992745422542810026153
   PubMed Web of Science ®Google Scholar
• McCaigCPerksCMHollyJMIntrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectinJ Cell Sci20021154293430312376561
   PubMed Web of Science ®Google Scholar
• PerksCMBowenSGillZPNewcombPVHollyJMDifferential IGF-independent effects of insulin-like growth factor binding proteins (1–6) on apoptosis of breast epithelial cellsJ Cell Biochem19997565266410572248
   PubMed Web of Science ®Google Scholar
• OhYMüllerHLLamsonGRosenfeldRGInsulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibitionJ Biol Chem199326814964149717686909
   PubMed Web of Science ®Google Scholar
• DupontJHolzenbergerMBiology of insulin-like growth factors in developmentBirth Defects Res C Embryo Today20036925727114745968
   PubMedGoogle Scholar
• YakarSSunHZhaoHMetabolic effects of IGF-I deficiency: lessons from mouse modelsPediatr Endocrinol Rev20053111916369209
   PubMedGoogle Scholar
• SilhaJVMurphyLJInsights from insulin-like growth factor binding protein transgenic miceEndocrinology20021433711371412239079
   PubMed Web of Science ®Google Scholar
• HollyJMPerksCMInsulin-like growth factor physiology: what we have learned from human studiesEndocrinol Metab Clin North Am201241249263v22682629
   PubMed Web of Science ®Google Scholar
• LittonJKGonzalez-AnguloAMWarnekeCLRelationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancerJ Clin Oncol2008264072407718757321
   PubMed Web of Science ®Google Scholar
• HealyLARyanAMCarrollPMetabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancerClin Oncol (R Coll Radiol)20102228128820189371
   PubMed Web of Science ®Google Scholar
• StebbingJSharmaANorthBA metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapyAnn Oncol20122386086621821546
   PubMed Web of Science ®Google Scholar
• PhoenixKNVumbacaFFoxMMEvansRClaffeyKPDietary energy availability affects primary and metastatic breast cancer and metformin efficacyBreast Cancer Res Treat201012333334420204498
   PubMed Web of Science ®Google Scholar
• ZengLBiernackaKMHollyJMHyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthaseEndocr Relat Cancer20101753955120356977
   PubMed Web of Science ®Google Scholar
• NarasimhanSDYenKTissenbaumHAConverging pathways in lifespan regulationCurr Biol200919R657R66619674551
   PubMed Web of Science ®Google Scholar
• HurstingSDSmithSMLashingerLMHarveyAEPerkinsSNCalories and carcinogenesis: lessons learned from 30 years of calorie restriction researchCarcinogenesis201031838919969554
   PubMed Web of Science ®Google Scholar
• De LorenzoMSBaljinnyamEVatnerDEAbarzuaPVatnerSFRabsonABCaloric restriction reduces growth of mammary tumors and metastasesCarcinogenesis2011321381138721665891
   PubMed Web of Science ®Google Scholar
• NogueiraLMLavigneJAChandramouliGVLuiHBarrettJCHurstingSDDose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1Cancer Med2012127528823342276
   PubMed Web of Science ®Google Scholar
• LinCCChengTLTsaiWHLoss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancySci Rep2012278523139858
   PubMed Web of Science ®Google Scholar
• KamarajugaddaSStemboroskiLCaiQGlucose oxidation modulates anoikis and tumor metastasisMol Cell Biol2012321893190722431524
   PubMed Web of Science ®Google Scholar
• Alisson-SilvaFFreire-de-LimaLDonadioJLIncrease of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cellsPLoS One20138e6047123593224
   PubMedGoogle Scholar
• O’ShaughnessyJExtending survival with chemotherapy in metastatic breast cancerOncologist200510Suppl 3202916368868
   PubMed Web of Science ®Google Scholar
• KalluriRWeinbergRAThe basics of epithelial-mesenchymal transitionJ Clin Invest20091191420142819487818
   PubMed Web of Science ®Google Scholar
• ThieryJPEpithelial-mesenchymal transitions in tumour progressionNat Rev Cancer2002244245412189386
   PubMed Web of Science ®Google Scholar
• ZeisbergMNeilsonEGBiomarkers for epithelial-mesenchymal transitionsJ Clin Invest20091191429143719487819
   PubMed Web of Science ®Google Scholar
• SarrioDRodriguez-PinillaSMHardissonDCanoAMoreno-BuenoGPalaciosJEpithelial-mesenchymal transition in breast cancer relates to the basal-like phenotypeCancer Res20086898999718281472
   PubMed Web of Science ®Google Scholar
• YuMBardiaAWittnerBSCirculating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal compositionScience201333958058423372014
   PubMed Web of Science ®Google Scholar
• AktasBTewesMFehmTHauchSKimmigRKasimir-BauerSStem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patientsBreast Cancer Res200911R4619589136
   PubMed Web of Science ®Google Scholar
• ManiSAGuoWLiaoMJThe epithelial-mesenchymal transition generates cells with properties of stem cellsCell200813370471518485877
   PubMed Web of Science ®Google Scholar
• Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMFProspective identification of tumorigenic breast cancer cellsProc Natl Acad Sci U S A20031003983398812629218
   PubMed Web of Science ®Google Scholar
• AbrahamBKFritzPMcClellanMHauptvogelPAthelogouMBrauchHPrevalence of CD44+/CD24−/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasisClin Cancer Res2005111154115915709183
   PubMed Web of Science ®Google Scholar
• MiyazonoKTransforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancerProc Jpn Acad Ser B Phys Biol Sci200985314323
   PubMed Web of Science ®Google Scholar
• BachmanKEParkBHDuel nature of TGF-beta signaling: tumor suppressor vs tumor promoterCurr Opin Oncol200517495415608513
   PubMed Web of Science ®Google Scholar
• XieWMertensJCReissDJAlterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray studyCancer Res20026249750511809701
   PubMed Web of Science ®Google Scholar
• FendrichVWaldmannJFeldmannGUnique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasiaEur J Endocrinol200916069570319176646
   PubMed Web of Science ®Google Scholar
• FangXCaiYLiuJTwist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewalOncogene2011304707472021602879
   PubMed Web of Science ®Google Scholar
• ManiSAYangJBrooksMMesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancersProc Natl Acad Sci U S A2007104100691007417537911
   PubMed Web of Science ®Google Scholar
• GuoFParker KerriganBCYangDPost-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitionsJ Hematol Oncol201471924598126
   PubMed Web of Science ®Google Scholar
• AlbergaABoulayJLKempeEDennefeldCHaenlinMThe snail gene required for mesoderm formation in Drosophila is expressed dynamically in derivatives of all three germ layersDevelopment19911119839921879366
   PubMed Web of Science ®Google Scholar
• PeinadoHBallestarEEstellerMCanoASnail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complexMol Cell Biol20042430631914673164
   PubMed Web of Science ®Google Scholar
• OlmedaDMoreno-BuenoGFloresJMFabraAPortilloFCanoASNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cellsCancer Res200767117211173118089802
   PubMed Web of Science ®Google Scholar
• MoodySEPerezDPanTCThe transcriptional repressor Snail promotes mammary tumor recurrenceCancer Cell2005819720916169465
   PubMed Web of Science ®Google Scholar
• DaveNGuaita-EsteruelasSGutarraSFunctional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transitionJ Biol Chem2011286120241203221317430
   PubMed Web of Science ®Google Scholar
• VincentTNeveEPJohnsonJRA SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transitionNat Cell Biol20091194395019597490
   PubMed Web of Science ®Google Scholar
• IseriODKarsMDArpaciFAtalayCPakIGunduzUDrug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression patternBiomed Pharmacother201165404521177063
   PubMed Web of Science ®Google Scholar
• KaaksRJohnsonTTikkKInsulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohortInt J Cancer20141342683269024248481
   PubMed Web of Science ®Google Scholar
• SchernhammerESHollyJMHunterDJPollakMNHankinsonSEInsulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study IIEndocr Relat Cancer20061358359216728584
   PubMed Web of Science ®Google Scholar
• BagliettoLEnglishDRHopperJLMorrisHATilleyWDGilesGGCirculating insulin-like growth factor-I and binding protein-3 and the risk of breast cancerCancer Epidemiol Biomarkers Prev20071676376817416768
   PubMed Web of Science ®Google Scholar
• Endogenous Hormones and Breast Cancer Collaborative GroupKeyTJApplebyPNReevesGKRoddamAWInsulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studiesLancet Oncol20101153054220472501
   PubMed Web of Science ®Google Scholar
• HawsawiYEl-GendyRTwelvesCSpeirsVBeattieJInsulin-like growth factor – oestradiol crosstalk and mammary gland tumourigenesisBiochim Biophys Acta2013183634535324189571
   PubMed Web of Science ®Google Scholar
• TsonisAIAfratisNGialeliCEvaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cellsFEBS J20132802248225923374155
   PubMed Web of Science ®Google Scholar
• Keinan-BokerLBueno De MesquitaHBKaaksRCirculating levels of insulin-like growth factor I, its binding proteins-1, -2, -3, C-peptide and risk of postmenopausal breast cancerInt J Cancer2003106909512794762
   PubMed Web of Science ®Google Scholar
• GronbaekHFlyvbjergAMellemkjaerLSerum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal womenCancer Epidemiol Biomarkers Prev2004131759176415533904
   PubMed Web of Science ®Google Scholar
• RenehanAGZwahlenMMinderCO’DwyerSTShaletSMEggerMInsulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisLancet20043631346135315110491
   PubMed Web of Science ®Google Scholar
• LivingstoneCIGF2 and cancerEndocr Relat Cancer201320R321R33924080445
   PubMed Web of Science ®Google Scholar
• HiranoHLopesMBLawsERJrInsulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomasNeuro-Oncology1999110911911550306
   PubMedGoogle Scholar
• SohdaTOkaYIwataKCo-localisation of insulin-like growth factor II and the proliferation marker MIB1 in hepatocellular carcinoma cellsJ Clin Pathol1997501351379155694
   PubMed Web of Science ®Google Scholar
• KawamotoKOnoderaHKondoSExpression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survivalOncology1998552422489560057
   PubMed Web of Science ®Google Scholar
• RoglerCEYangDRossettiLAltered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic miceJ Biol Chem199426913779137847514593
   PubMed Web of Science ®Google Scholar
• GuerraFKEijanAMPuricelliLVarying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing abilityInt J Cancer1996658128208631597
   PubMed Web of Science ®Google Scholar
• PapaVGliozzoBClarkGMInsulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancerCancer Res199353373637408339284
   PubMed Web of Science ®Google Scholar
• JammesHPeyratJPBanEInsulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysisBr J Cancer1992662482531323990
   PubMed Web of Science ®Google Scholar
• ValentinisBBasergaRIGF-I receptor signalling in transformation and differentiationMol Pathol20015413313711376123
   PubMedGoogle Scholar
• PeruzziFPriscoMDewsMMultiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosisMol Cell Biol1999197203721510490655
   PubMed Web of Science ®Google Scholar
• KimHJLitzenburgerBCCuiXConstitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snailMol Cell Biol2007273165317517296734
   PubMed Web of Science ®Google Scholar
• XieYSkyttingBNilssonGBrodinBLarssonOExpression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotypeCancer Res1999593588359110446966
   PubMed Web of Science ®Google Scholar
• LongLRubinRBrodtPEnhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptorExp Cell Res19982381161219457063
   PubMed Web of Science ®Google Scholar
• SaldanaSMLeeHHLoweryFJInhibition of type I insulin-like growth factor receptor signaling attenuates the development of breast cancer brain metastasisPLoS One20138e7340624039934
   PubMed Web of Science ®Google Scholar
• ChangLGrahamPHHaoJAcquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistanceCell Death Dis20134e87524157869
   PubMed Web of Science ®Google Scholar
• IrieHYPearlineRVGruenebergDDistinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transitionJ Cell Biol20051711023103416365168
   PubMed Web of Science ®Google Scholar
• GuvakovaMASurmaczEThe activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillinExp Cell Res199925124425510438590
   PubMed Web of Science ®Google Scholar
• SorokinAVChenJMEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cellsOncogene2013323130313822824790
   PubMed Web of Science ®Google Scholar
• LorenzattiGHuangWPalACabanillasAMKleerCGCCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancerJ Cell Sci20111241752175821525039
   PubMed Web of Science ®Google Scholar
• GrahamTRZhauHEOdero-MarahVAInsulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cellsCancer Res2008682479248818381457
   PubMed Web of Science ®Google Scholar
• PizonMZimonDCarlSPachmannUPachmannKCamaraOHeterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancerEcancermedicalscience2013734323983815
   PubMedGoogle Scholar
• DugganCWangCYNeuhouserMLAssociations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancerInt J Cancer20131321191120022847383
   PubMed Web of Science ®Google Scholar
• MorgilloFDe VitaFAntoniolGSerum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancerCurr Oncol201320e283e28823904766
   PubMed Web of Science ®Google Scholar
• DupontJKhanJQuBHMetzlerPHelmanLLeRoithDInsulin and IGF-1 induce different patterns of gene expression in mouse fibroblast NIH-3T3 cells: identification by cDNA microarray analysisEndocrinology20011424969497511606465
   PubMed Web of Science ®Google Scholar
• DupontJFernandezAMGlackinCAHelmanLLeRoithDInsulin-like growth factor 1 (IGF-1)-induced twist expression is involved in the anti-apoptotic effects of the IGF-1 receptorJ Biol Chem2001276266992670711323435
   PubMed Web of Science ®Google Scholar
• SciaccaLCostantinoAPandiniGInsulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanismOncogene1999182471247910229198
   PubMed Web of Science ®Google Scholar
• PandiniGVigneriRCostantinoAInsulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signalingClin Cancer Res199951935194410430101
   PubMed Web of Science ®Google Scholar
• HarringtonSCWerohaSJReynoldsCSumanVJLingleWLHaluskaPQuantifying insulin receptor isoform expression in FFPE breast tumorsGrowth Horm IGF Res20122210811522551578
   PubMed Web of Science ®Google Scholar
• OatesAJSchumakerLMJenkinsSBThe mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor geneBreast Cancer Res Treat1998472692819516081
   PubMed Web of Science ®Google Scholar
• De SouzaATHankinsGRWashingtonMKFineRLOrtonTCJirtleRLFrequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumorsOncogene199510172517297753549
   PubMed Web of Science ®Google Scholar
• ByrdJCDeviGRde SouzaATJirtleRLMacDonaldRGDisruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutationsJ Biol Chem1999274244082441610446221
   PubMed Web of Science ®Google Scholar
• O’GormanDBCostelloMWeissJFirthSMScottCDDecreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cellsCancer Res1999595692569410582686
   PubMed Web of Science ®Google Scholar
• SouzaRFWangSThakarMExpression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cellsOncogene1999184063406810435587
   PubMed Web of Science ®Google Scholar
• OhYMullerHLNgLRosenfeldRGTransforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 actionJ Biol Chem199527013589135927539790
   PubMed Web of Science ®Google Scholar
• ShemerJYaronAWernerHRegulation of insulin-like growth factor (IGF) binding protein-5 in the T47D human breast carcinoma cell line by IGF-I and retinoic acidJ Clin Endocrinol Metab199377124612507521344
   PubMed Web of Science ®Google Scholar
• ColstonKWPerksCMXieSPHollyJMGrowth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3J Mol Endocrinol1998201571629513092
   PubMed Web of Science ®Google Scholar
• KarasMKleinmanDDanilenkoMComponents of the IGF system mediate the opposing effects of tamoxifen on endometrial and breast cancer cell growthProg Growth Factor Res199565135208817696
   PubMedGoogle Scholar
• NishimuraAFujimotoMOguchiSFusunyanRDMacDermottRPSandersonIRShort-chain fatty acids regulate IGF-binding protein secretion by intestinal epithelial cellsAm J Physiol1998275E55E639688874
   PubMedGoogle Scholar
• ClemmonsDRCamacho-HubnerCCoronadoEOsborneCKInsulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor statusEndocrinology1990127267926861701124
   PubMed Web of Science ®Google Scholar
• YuHLevesqueMAKhosraviMJPapanastasiou-DiamandiAClarkGMDiamandisEPInsulin-like growth factor-binding protein-3 and breast cancer survivalInt J Cancer1998796246289842972
   PubMed Web of Science ®Google Scholar
• RochaRLHilsenbeckSGJacksonJGInsulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survivalClin Cancer Res199731031099815544
   PubMed Web of Science ®Google Scholar
• VesteySPerksCSenCCalderCHollyJWintersZImmunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcomeBreast Cancer Res20057R119R12915642160
   PubMed Web of Science ®Google Scholar
• HollowoodADLaiTPerksCMNewcombPVAldersonDHollyJMIGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiationInt J Cancer20008833634111054660
   PubMed Web of Science ®Google Scholar
• GillZPPerksCMNewcombPVHollyJMInsulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent mannerJ Biol Chem199727225602256079325280
   PubMed Web of Science ®Google Scholar
• WilliamsACCollardTJPerksCMIncreased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cellsCancer Res200060222710646845
   PubMed Web of Science ®Google Scholar
• FowlerCAPerksCMNewcombPVSavagePBFarndonJRHollyJMInsulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cellsInt J Cancer20008844845311054675
   PubMed Web of Science ®Google Scholar
• McCaigCFowlerCALaurenceNJDifferential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cellsBr J Cancer2002861963196912085194
   PubMed Web of Science ®Google Scholar
• YuQBanerjeeKPatersonJAlamiNShiryLLeyland-JonesBIGFBP-3: Single Agent and Synergistic Effects with Chemotherapeutic Drugs on Solid Tumor Models, AACRProceedings of the AACR, 172: Abstract 755Washington DC2003
   Google Scholar
• McIntoshJDennisonGHollyJMIGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectinJ Biol Chem2010285387883880020851879
   PubMed Web of Science ®Google Scholar
• BurrowsCHollyJMLaurenceNJInsulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexesEndocrinology20061473484350016614079
   PubMed Web of Science ®Google Scholar
• IoachimECharchantiABriasoulisEImmunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progressionEur J Cancer2002382362237012460779
   PubMed Web of Science ®Google Scholar
• BaxterRCIGF binding proteins in cancer: mechanistic and clinical insightsNat Rev Cancer20141432934124722429
   PubMed Web of Science ®Google Scholar
• JohnsonMAFirthSMIGFBP-3: a cell fate pivot in cancer and diseaseGrowth Horm IGF Res201424516417324953254
   PubMed Web of Science ®Google Scholar
• WalshLADamjanovskiSIGF-1 increases invasive potential of MCF 7 breast cancer cells and induces activation of latent TGF-β1 resulting in epithelial to mesenchymal transitionCell Commun Signal201191021535875
   PubMed Web of Science ®Google Scholar
• ReissMBarcellos-HoffMHTransforming growth factor-beta in breast cancer: a working hypothesisBreast Cancer Res Treat19974581959285120
   PubMed Web of Science ®Google Scholar
• DieciMVOrvietoEDominiciMContePGuarneriVRare breast cancer subtypes: histological, molecular, and clinical peculiaritiesOncologist20141980581324969162
   PubMed Web of Science ®Google Scholar
• KittanehMMonteroAJGluckSMolecular profiling for breast cancer: a comprehensive reviewBiomarkers Cancer201356170
   Google Scholar
• BooneDNLeeAVTargeting the insulin-like growth factor receptor: developing biomarkers from gene expression profilingCrit Rev Oncog20121716117322471706
   PubMedGoogle Scholar
• LeeAVYeeDTargeting IGF-1R: at a crossroadOncology (Williston Park)201125535536 discussion 55121717908
   PubMed Web of Science ®Google Scholar
• ChenHXSharonEIGF-1R as an anti-cancer target – trials and tribulationsChin J Cancer20133224225223601239
   PubMed Web of Science ®Google Scholar
• AlamiNPageVYuQRecombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer modelsGrowth Horm IGF Res20081848749618502161
   PubMed Web of Science ®Google Scholar